The Cas­sa­va saga con­tin­ues as test­ing part­ner de­nies prepar­ing taint­ed Alzheimer's da­ta

The news keeps get­ting worse over at Cas­sa­va Sci­ences.

In a state­ment Fri­day, test­ing com­pa­ny Quan­ter­ix de­nied in­ter­pret­ing or prepar­ing key Alzheimer’s da­ta from Cas­sa­va that is now the sub­ject of a cit­i­zen pe­ti­tion claim­ing the re­sults had been fal­si­fied.

Quan­ter­ix’s ver­sion of the sto­ry goes like this:

Cas­sa­va pre­vi­ous­ly en­gaged Quan­ter­ix’ Ac­cel­er­a­tor lab­o­ra­to­ry to per­form sam­ple test­ing based on blind­ed sam­ples pro­vid­ed by Cas­sa­va. Quan­ter­ix or its em­ploy­ees did not in­ter­pret the test re­sults or pre­pare the da­ta charts pre­sent­ed by Cas­sa­va at the Alzheimer’s As­so­ci­a­tion In­ter­na­tion­al Con­fer­ence (AA­IC) in Ju­ly 2021 or oth­er­wise.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER